Collegium to Participate in Piper Sandler 34th Annual Healthcare Conference
Rhea-AI Summary
Collegium Pharmaceutical (Nasdaq: COLL) announced participation in the Piper Sandler 34th Annual Healthcare Conference in New York from November 29 to December 1, 2022. Management will engage in a fireside chat on November 30, 2022, at 1:30 p.m. ET. The discussion will be webcast live and accessible via the Investors section of Collegium's website, with a replay available for 90 days post-event. Collegium is dedicated to enhancing the lives of individuals with serious medical conditions, headquartered in Stoughton, Massachusetts.
Positive
- None.
Negative
- None.
News Market Reaction – COLL
In the trading session that priced this news, COLL gained 1.81%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
STOUGHTON, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference being held in New York, NY from November 29 to December 1, 2022.
Details of the event are as follows:
Fireside Chat Date and Time: Wednesday, November 30, 2022, at 1:30 p.m. ET
The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Collegium Pharmaceutical, Inc.
Collegium is a diversified, specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Contact:
Dawn Schottlandt
Argot Partners
collegium@argotpartners.com
